17672 Legislation
Authorizing the use of the rotunda of the Capitol for a ceremony to honor the late Senator Lindsey O. Graham.
- senate
- house
Updated 7/23/2026Last progress July 21, 2026
Track bills, resolutions, and amendments moving through Congress
Authorizing the use of the rotunda of the Capitol for a ceremony to honor the late Senator Lindsey O. Graham.
Putting Patients First by Strengthening Provider Accountability in FECA Act
The bill strengthens the government’s ability to stop payments to providers convicted of fraud—potentially saving taxpayer money and improving accountability—while risking payment delays, service disruptions, and added administrative burdens unless implementing regulations provide strong procedural safeguards.
Next-Generation Geothermal Research and Development Act
The bill accelerates next‑generation geothermal innovation and commercial deployment through targeted funding, generous cost‑share grants, data sharing, and workforce support, but it increases taxpayer costs and raises local environmental, proprietary, and implementation‑risk concerns that require careful mitigation.
Federal Relocation Payment Improvement Act
The bill streamlines and standardizes relocation payments for federal employees and adds appeal rights, trading faster, more consistent assistance for the risk that some workers may receive lower reimbursements and agencies will face implementation and fairness challenges.
NIH IMPROVE Act
The bill invests modest but sustained federal funding to build research, targeted interventions, and local evidence to reduce maternal mortality and address disparities, trading a delayed and potentially uneven implementation (and modest taxpayer cost) for the prospect of longer-term, locally tailored maternal health improvements.
To name the Department of Veterans Affairs multispecialty clinic in Marietta, Georgia, as the "Colonel Michael H. Boyce Department of Veterans Affairs Multispecialty Clinic".
The bill clarifies and standardizes the VA clinic name in Marietta—improving veterans' ability to find and be referred to care—while imposing only minor costs and short-term administrative work to update records and materials.
FIT Procurement Act
The bill seeks to speed and modernize federal ICT procurement and expand small‑business access through training, higher thresholds, and streamlined rules, but those efficiencies come with increased risks to competition, oversight, contractor performance, and implementation—made more acute by a prohibition on new funding to carry out the reforms.
Accelerating Access to Dementia and Alzheimer’s Provider Training Act
The bill extends program authorization and explicitly opens eligibility to more public and nonprofit organizations—preserving access to federal support—but raises the prospect of higher federal spending and greater competition that could dilute funding for current recipients.
DeOndra Dixon INCLUDE Project Act of 2025
The bill directs more coordinated federal research and clinical trial activity toward Down syndrome—likely improving treatments and access for affected individuals—while raising federal costs and creating a risk of shifting resources and limiting stakeholder input unless paired with additional funding and stronger engagement requirements.
To amend the Research and Development, Competition, and Innovation Act to support nucleic acid screening, and for other purposes.
The bill strengthens biosecurity by funding standards and convening stakeholders to reduce risks from synthesized sequences, but it imposes compliance burdens, raises privacy concerns, and may be underfunded relative to the scope and evolving nature of the risks.
Destruction of Hazardous Imports Act
The bill strengthens public‑health protection by empowering the FDA to stop and destroy hazardous imports and clarifies rulemaking timelines, but it shifts costs and legal risks onto importers, logistics providers, and small businesses and raises due‑process and waste concerns.
Action for Dental Health Act
The bill provides modest, flexible increases in funding and authorization to strengthen local public-health preparedness and multi-year projects, but it raises potential federal spending and risks program shortfalls if appropriations do not materialize.
Choices for Increased Mobility Act of 2026
The bill clarifies Medicare payment and coding for ultralight wheelchair bases and increases price transparency, but risks higher out‑of‑pocket costs and access barriers for patients and added administrative burdens for suppliers.
To reauthorize and make improvements to Federal programs relating to the prevention, detection, and treatment of traumatic brain injuries, and for other purposes.
The bill strengthens TBI surveillance, prevention guidance, research on long‑term effects, and multiyear federal support for state/tribal programs, at the trade-off of placing budget and implementation pressures on state/tribal budgets and CDC resources and raising privacy concerns unless funding and safeguards are addressed.
Affordable Prescriptions for Patients Act
The bill reduces litigation risk and increases predictability for biosimilar/generic applicants — potentially speeding competition and lowering costs — at the expense of narrower immediate enforceability of innovators' patent portfolios and added procedural disputes and uneven treatment for pending cases.
Expanding Whistleblower Protections for Contractors Act of 2026
The bill substantially expands and clarifies whistleblower protections and accountability for contractors and federal officials—strengthening oversight and workers' rights—while increasing compliance and litigation costs, adding administrative burdens, and creating handling complexities for national‑security‑sensitive disclosures.
Stem Cell Therapeutic and Research Reauthorization Act of 2025
The bill extends and modestly increases federal support to preserve and improve access to high‑quality cord‑blood/stem‑cell units for transplants, while giving HHS broader discretion that raises planning, consent, and representation risks and leaves actual funding dependent on future appropriations.
To reauthorize the Young Women’s Breast Health Education and Awareness Requires Learning Young Act of 2009.
The bill helps preserve and modernize CDC-led breast-health education and program administration to support early detection, but it lacks guaranteed funding and clear limits, creating uncertainty and a risk that services could be narrowed or reduced.
To reauthorize the Kay Hagan Tick Act, and for other purposes.
The bill extends federal support and strengthens HHS capacity to detect and respond to vector‑borne diseases through 2030—benefiting state/local public health systems and vulnerable communities—at the cost of increased federal spending and somewhat reduced transparency about advisory roles.
FDA Modernization Act 3.0
The bill clarifies and accelerates FDA rules for 'nonclinical' tests—improving regulatory clarity and predictability for researchers and health systems—at the cost of reduced public notice, potential short-term compliance costs, and some risk of interpretive gaps about which studies are covered.
Stop Secret Spending Act of 2025
The bill increases transparency and data quality for many federal awards—improving public oversight and usability of spending data—at the cost of added administrative burdens, delayed implementation, and continued gaps in visibility for classified, excluded, and lower‑tier awards.
Continuing Appropriations Act, 2027
Main Street Act
The bill shifts oversight toward tailored, faster, and more predictable regulation that reduces burdens for many smaller institutions and their customers, but it does so at the cost of reduced supervisory discretion and prudential coverage that could raise systemic risk and taxpayer exposure.
Value Over Cost Act of 2025
The bill gives agencies clearer flexibility to favor higher-quality, mission-aligned procurements over strict lowest price, improving performance and transparency but raising risks of higher taxpayer costs, reduced contractor competition, and more centralized/slower decision-making.
To designate the community-based outpatient clinic of the Department of Veterans Affairs in Lafayette, Louisiana, as the "Rodney C. Hamilton Sr. VA Clinic".
The bill honors a local veteran and clarifies official references to the Lafayette VA clinic, at the cost of small administrative expenses and a risk of local disagreement over the choice of honoree.
To name the Department of Veterans Affairs community-based outpatient clinic in Newton, New Jersey, as the "Anthony "Tony" J. Gallopo VA Clinic".
The bill provides local symbolic recognition by renaming a VA outpatient clinic and updating records, offering modest clarity and honor at minimal cost but without adding services or benefits for veterans.
To name the Department of Veterans Affairs community-based outpatient clinic in San Jose, California, as the "Corporal Patrick D. Tillman VA Clinic".
The bill formally honors Pat Tillman by naming a VA clinic and recognizing his service—boosting veterans' recognition and reducing naming ambiguity—at the cost of minor taxpayer expenses and possible local controversy, without altering services.
Captain Paul W. Bud Bucha VA Medical Center Act of 2025
The bill symbolically honors veterans and clarifies a VA facility's name—helping awareness, destigmatization, and administrative consistency—while offering no new funding or policy changes and imposing only minor administrative costs and short-term transition confusion.
Failing Bank Acquisition Fairness Act
The bill raises transparency and legal safeguards to better protect taxpayers, depositors, and the Deposit Insurance Fund, but its tighter approval standards and reporting requirements may slow emergency bank resolutions and increase administrative costs.
Common Cents Act
The bill reduces federal coin-production costs and gives the Mint flexibility (by ending penny circulation and permitting a cheaper nickel composition) at the expense of modest consumer price/rounding effects, potential equipment costs for businesses, and small cultural/communication downsides.
